Grace Therapeutics, Inc. (GRCE)
NASDAQ: GRCE · Real-Time Price · USD
1.870
+0.060 (3.31%)
At close: Oct 27, 2026, 4:00 PM EDT
1.870
0.00 (0.00%)
After-hours: Oct 27, 2026, 7:30 PM EDT
Grace Therapeutics Market Cap
Grace Therapeutics has a market cap or net worth of $39.34 million as of October 27, 2026. It is the 32,098th most valuable company in the world and the 4,800th biggest in the United States. Its market cap has decreased by 9.36% in one year.
Market Cap
39.34M
Enterprise Value
25.58M
1-Year Change
-9.36%
Global Rank
Country Rank
#4,800 United States
Category
ChartMarket Cap Chart
Since January 9, 2015, Grace Therapeutics's market cap has decreased from $6.81B to $39.34M, a decrease of -99.42%. That is a compound annual growth rate of -35.38%.
| Date | Market Cap | % Change |
|---|---|---|
| Oct 27, 2026 | 39.34M | -19.56% |
| Dec 31, 2025 | 48.90M | 29.02% |
| Dec 31, 2024 | 37.90M | 39.34% |
| Dec 29, 2023 | 27.20M | 21.43% |
| Dec 30, 2022 | 22.40M | -59.86% |
| Dec 31, 2021 | 55.80M | 77.14% |
| Dec 31, 2020 | 31.50M | -84.91% |
| Dec 31, 2019 | 208.70M | 584.26% |
| Dec 31, 2018 | 30.50M | 119.42% |
| Dec 29, 2017 | 13.90M | 3.73% |
| Dec 30, 2016 | 13.40M | -99.80% |
| Jan 9, 2015 | 6.81B | - |
View and export this data all the way back to 2015. Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Adicet Bio | 42.95M |
| Estrella Immunopharma | 42.85M |
| Annovis Bio | 42.58M |
| Serina Therapeutics | 41.91M |
| Alterity Therapeutics | 41.09M |
| INmune Bio | 40.52M |
| GridAI Technologies | 39.69M |
| Instil Bio | 39.61M |